Mannkind Corp (MNKD)

07:32 AM

H.C. Wainwright assumes coverage on MannKind stock with Buy rating - Investing.com

07:32 AM

Jul 15, 2025

What makes MannKind Corporation stock price move sharplyLow Risk Scalping Alerts - Newser

Jul 15, 2025

Jul 15, 2025

Why MannKind Corporation stock attracts strong analyst attentionGrowth Stock Monitor - Newser

Jul 15, 2025

Jul 14, 2025

High Growth Tech Stocks To Watch In The US July 2025 - Yahoo Finance

Jul 14, 2025

Jul 11, 2025

Wells Fargo Maintains a Buy Rating on MannKind Corporation (MNKD), Sets a $9 PT - Yahoo Finance

Jul 11, 2025

Jul 11, 2025

13 Best Healthcare Stocks to Buy Under $10 - Insider Monkey

Jul 11, 2025

Jul 07, 2025

Wedbush Remains Bullish on MannKind Corporation (MNKD) - Insider Monkey

Jul 07, 2025

Jul 01, 2025

MannKind Corp stock hits 52-week low at $3.63 - Investing.com

Jul 01, 2025

Jun 25, 2025

Is Day One Biopharmaceuticals, Inc. overvalued or undervalued? - MarketsMojo

Jun 25, 2025

Jun 24, 2025

Leerink Partners Slashes MannKind Corporation’s (MNKD) Price Target to $7, Keeps a Buy Rating - Yahoo Finance

Jun 24, 2025

Jun 23, 2025

MannKind (MNKD) Presents Pediatric Insulin Trial Data - Yahoo Finance

Jun 23, 2025

Jun 17, 2025

MannKind stock hits 52-week low at $3.70 - Investing.com

Jun 17, 2025

Jun 11, 2025

Top 3 Health Care Stocks That May Rocket Higher This Quarter - Benzinga

Jun 11, 2025

Jun 10, 2025

Insider Sell: Steven Binder Sells 64,085 Shares of MannKind Corp (MNKD) - GuruFocus

Jun 10, 2025

Jun 10, 2025

MannKind director Steven Binder sells $256,340 in shares By Investing.com - Investing.com South Africa

Jun 10, 2025

Jun 10, 2025

MannKind director Steven Binder sells $256,340 in shares - Investing.com Australia

Jun 10, 2025

Jun 10, 2025

Phase II home run: Insmed’s TPIP hits hypertension endpoints - BioWorld MedTech

Jun 10, 2025

Jun 10, 2025

MannKind stock touches 52-week low at $4.04 amid market shifts - Investing.com Nigeria

Jun 10, 2025

Jun 09, 2025

MannKind to present inhaled insulin study at ADA event By Investing.com - Investing.com Canada

Jun 09, 2025

Jun 09, 2025

MannKind to present inhaled insulin study at ADA event - Investing.com

Jun 09, 2025

Jun 09, 2025

Breakthrough in Pediatric Diabetes Care: MannKind Phase 3 Trial Data Reveals New Inhaled Insulin Treatment Option - Stock Titan

Jun 09, 2025

Jun 05, 2025

MannKind at Jefferies Global Healthcare: Strategic Growth and Innovation By Investing.com - Investing.com Canada

Jun 05, 2025

Jun 05, 2025

MannKind at Jefferies Global Healthcare: Strategic Growth and Innovation - Investing.com Australia

Jun 05, 2025

Jun 05, 2025

MannKind To Present At Jefferies Global Healthcare Conference; Webcast At 2:35 PM ET - Nasdaq

Jun 05, 2025

May 28, 2025

Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit - Seeking Alpha

May 28, 2025

May 27, 2025

Type 1 Diabetes Didn't Stop This INDYCAR Driver: Conor Daly Inspires Detroit Youth Before Grand Prix - Stock Titan

May 27, 2025

May 27, 2025

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition - Seeking Alpha

May 27, 2025

May 23, 2025

Mannkind Corp (MNKD) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

May 23, 2025

May 20, 2025

MannKind stock touches 52-week low at $4.34 amid market shifts - Investing.com Canada

May 20, 2025

May 20, 2025

MannKind at RBC Conference: Strategic Growth and Innovation By Investing.com - Investing.com Canada

May 20, 2025

May 20, 2025

MannKind at RBC Conference: Strategic Growth and Innovation - Investing.com

May 20, 2025

May 20, 2025

MannKind To Present At RBC Capital Markets Conference; Webcast At 8:00 AM ET - Nasdaq

May 20, 2025

May 16, 2025

Most adults with type 1 diabetes using inhaled insulin increase daily dose over 30 weeks - Healio

May 16, 2025

May 16, 2025

MannKind corp director Steven Binder sells $375,875 in stock By Investing.com - Investing.com UK

May 16, 2025

May 15, 2025

MannKind EVP David Thomson sells shares worth $150,597 By Investing.com - Investing.com India

May 15, 2025

May 15, 2025

MannKind EVP David Thomson sells shares worth $150,597 - Investing.com

May 15, 2025

May 15, 2025

MannKind corp director Steven Binder sells $375,875 in stock - Investing.com

May 15, 2025

May 15, 2025

MannKind CMO steps down, transition plan set - Investing.com

May 15, 2025

May 13, 2025

MannKind to Present at Upcoming Investor Conferences - The Globe and Mail

May 13, 2025

May 11, 2025

MannKind Corporation (NASDAQ:MNKD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025

May 10, 2025

MannKind First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 10, 2025

May 09, 2025

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025

May 09, 2025

Decoding MannKind Corp (MNKD): A Strategic SWOT Insight - GuruFocus

May 09, 2025

May 08, 2025

10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey

May 08, 2025

May 08, 2025

MannKind: Q1 Earnings Snapshot - MySA

May 08, 2025

May 08, 2025

Earnings call transcript: MannKind Q1 2025 revenue beats, stock dips - Investing.com

May 08, 2025

May 08, 2025

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Gr - GuruFocus

May 08, 2025

May 08, 2025

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Growth | MNKD Stock News - GuruFocus

May 08, 2025